Skip to main content

SUMMIT Trial

Meaning

The SUMMIT Trial is a significant, ongoing phase 3 clinical study designed to evaluate the efficacy and safety of a specific therapeutic agent, often a GLP-1/GIP receptor agonist like tirzepatide, in patients with heart failure with preserved ejection fraction (HFpEF) and coexisting obesity. This landmark trial aims to determine if the agent can improve cardiovascular outcomes, functional status, and quality of life in this high-risk population. Its findings are expected to redefine the clinical management of cardiorenal-metabolic syndrome, integrating endocrinology with cardiology.